🇧🇼
Peptide Laws in Botswana
BW · Africa · 23 peptides tracked
Grey AreaEnforcement: Moderate
Are Peptides Legal in Botswana?
Botswana has a moderate regulatory environment with personal import provisions for medicines. There is no domestic peptide market, but bringing in small quantities for personal use with supporting documentation is generally accepted. Prescription peptides may be available through private clinics in Gaborone. Enforcement is moderate, so having a doctor's letter is recommended.
23
BannedCan You Buy Peptides in Botswana?
23 peptide(s) are banned: Tirzepatide, Selank, MOTS-c, TB-500, GHK-Cu, and 18 more. Purchasing or possessing these is illegal.
Traveling to Botswana with Peptides
When traveling to Botswana with peptides, the legality depends on each peptide's classification. Do not bring banned substances (Tirzepatide, Selank, MOTS-c, TB-500, GHK-Cu, and 18 more) — these could result in criminal penalties at customs. Enforcement in Botswana is rated as "Moderate." Always declare pharmaceutical products at customs and carry documentation of any prescriptions.
New to peptides? Start with the basics on peptide.camp →
Need to source peptides for Botswana? Get verified wholesale quotes on peptide.broker →
Traveling to Botswana with peptides? TSA tips, packing guides & the peptide travel case on peptide.travel →
Peptide Regulations in Botswana
| Peptide | Status | Rx Required | Schedule | Detail | Source |
|---|---|---|---|---|---|
| Tirzepatide | Banned | Yes | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Selank | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| MOTS-c | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| TB-500 | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| GHK-Cu | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Ipamorelin | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Semaglutide | Banned | Yes | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| CJC-1295 | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Semax | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| BPC-157 | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| NAD+ | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Retatrutide | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| AOD-9604 | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Glutathione | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| DSIP | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Epithalon | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| KPV | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| HGH | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Liraglutide | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Melanotan II | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| MK-677 | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| Vitamin B12 | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
| PT-141 | Banned | No | Unregistered Regulated Product | Regulated by BoMRA. A new Medicines and Related Substances Act 2025 (No. 29 of 2025) was assented on 24 December 2025 but COMMENCES ON NOTICE, and no commencement order was located - until it commences the 2013 Act continues to operate, so verify which regime applies before relying on this. Under the 2025 Act, s.35(1) prohibits possessing or controlling any regulated product for the purposes of importing, manufacturing, distributing, selling, advertising, STORING or dispensing unless registered - a possession-for-purpose offence, broader than a pure sale prohibition. Penalty under s.35(11): a fine up to P10,000,000 or imprisonment up to 10 YEARS, or both. Personal use is addressed: s.35(5)(a) allows exemption for a product prescribed outside Botswana for a patient's personal use, and s.64 permits a traveller to bring in quantities required for their own or accompanying family members' treatment, excluding prohibited products, narcotics, psychotropics and precursors. | Official |
Data is researcher-verified but not legal advice. Always consult local regulations before purchasing, importing, or traveling with peptides. Last verified: 2026-02-28.